Fmr LLC Has $126.46 Million Position in The Clorox Company (NYSE:CLX)

Fmr LLC raised its stake in The Clorox Company (NYSE:CLX) by 27.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 776,232 shares of the company’s stock after acquiring an additional 168,111 shares during the period. Fmr LLC owned approximately 0.63% of Clorox worth $126,456,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Prospera Private Wealth LLC bought a new stake in Clorox during the third quarter worth about $27,000. Innealta Capital LLC bought a new stake in shares of Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC boosted its position in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after acquiring an additional 130 shares in the last quarter. Family Firm Inc. bought a new position in Clorox in the second quarter valued at approximately $31,000. Finally, Quarry LP raised its position in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.57% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on CLX. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Evercore ISI lowered their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. DA Davidson increased their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Finally, BNP Paribas raised shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $155.00.

Clorox Trading Up 0.3 %

Shares of CLX stock opened at $167.08 on Wednesday. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.35. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The stock has a market cap of $20.68 billion, a price-to-earnings ratio of 58.22, a PEG ratio of 3.08 and a beta of 0.42. The stock has a 50-day moving average of $163.18 and a 200-day moving average of $149.90.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 EPS. On average, equities research analysts forecast that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.92%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.